|
HY-135932-50mg
|
MedChemexpress LLC
|
m-PEG8-O-alkyne [CAS 880081-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-139385A-100mg
|
MedChemexpress LLC
|
mPEG-DSPE (MW 2000) (sodium)
|
|
Cancer-programmed cell death
|
|
|
HY-139385A-50mg
|
MedChemexpress LLC
|
mPEG-DSPE (MW 2000) (sodium)
|
|
Cancer-programmed cell death
|
|
|
HY-140696E-1g
|
MedChemexpress LLC
|
m-PEG-OH (MW 1000) [CAS 9004-74-4]
|
|
|
|
|
HY-140696E-5g
|
MedChemexpress LLC
|
m-PEG-OH (MW 1000) [CAS 9004-74-4]
|
|
|
|
|
HY-14609-10mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-5mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-50mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-1mL
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609A-250mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-10mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-100mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-5mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-50mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-1mL
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-148516-10mg
|
MedChemexpress LLC
|
MPH-220 [CAS 2649776-79-2]
|
|
|
|
|
HY-148516-100mg
|
MedChemexpress LLC
|
MPH-220 [CAS 2649776-79-2]
|
|
|
|
|
HY-148516-25mg
|
MedChemexpress LLC
|
MPH-220 [CAS 2649776-79-2]
|
|
|
|
|
HY-148516-5mg
|
MedChemexpress LLC
|
MPH-220 [CAS 2649776-79-2]
|
|
|
|
|
HY-148516-50mg
|
MedChemexpress LLC
|
MPH-220 [CAS 2649776-79-2]
|
|
|
|
|
HY-12660-10mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-2mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-5mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-50mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-1mL
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
